{"id":868798,"date":"2025-07-11T08:32:10","date_gmt":"2025-07-11T12:32:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/"},"modified":"2025-07-11T08:32:10","modified_gmt":"2025-07-11T12:32:10","slug":"evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/","title":{"rendered":"Evaxion finalizes agreement with EIB to convert debt into equity"},"content":{"rendered":"<div class=\"mw_release\">\n<ul>\n<li>\n          <b>Evaxion and the European Investment Bank (EIB) have finalized a debt settlement agreement of \u20ac3.5 million out of Evaxion\u2019s \u20ac7 million loan with EIB, to be used for EIB to purchase \u20ac3.5 million worth of ordinary Evaxion warrants<\/b>\n        <\/li>\n<li style=\"text-align:justify\">\n          <b>EIB will purchase the warrants at a price of $4.87 corresponding to a premium of 89% to the share price by market close yesterday <\/b>\n        <\/li>\n<li style=\"text-align:justify\">\n          <b>The agreement immediately increases Evaxion\u2019s equity by $4.1 million (\u20ac3.5 million)<\/b>\n        <\/li>\n<li style=\"text-align:justify\">\n          <b>Further, the agreement also substantially reduces Evaxion\u2019s overall liabilities, simplifies its balance sheet and improves its financial flexibility and cash flow<\/b>\n        <\/li>\n<\/ul>\n<p align=\"justify\">COPENHAGEN, Denmark, July 11, 2025 &#8211; Evaxion A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company specializing in developing AI-Immunology\u2122 powered vaccines, has finalized its agreement with the European Investment Bank (EIB) to convert debt into equity.<\/p>\n<p align=\"justify\">EIB will convert \u20ac3.5 million of its \u20ac7 million loan to Evaxion into equity via a purchase of ordinary Evaxion warrants at a price of $4.87, corresponding to a premium of 89% to the share price by market close yesterday. The agreement immediately increases Evaxion\u2019s equity by $4.1 million (\u20ac3.5 million), bolstering Evaxion\u2019s capital structure. Further, it substantially reduces Evaxion\u2019s overall liabilities, simplifies its balance sheet and improves its financial flexibility and cash flow.<\/p>\n<p align=\"justify\">\u201cWe are delighted to finalize the agreement with the EIB on favourable terms for Evaxion and our shareholders. I would like to thank the EIB for their support and very constructive approach in the negotiations. The agreement further simplifies our balance sheet and improves our cash flow, which is an important element in the financial management of the company,\u201d says Thomas F. Schmidt, CFO of Evaxion.<\/p>\n<p align=\"justify\">\n        <b>Contact information<\/b>\u00a0<br \/>Evaxion A\/S<br \/>Mads Kronborg<br \/>Vice President, Investor Relations &amp; Communication<br \/>+45 53 54 82 96 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SvOUCkk145v_9-RiQI-Hi2a69qP4qyPvyLj0PPliXohzIeYLnSr5y3b9VGQ4rX5ww36CnW4t6k22Gn5MNly3pw==\" rel=\"nofollow\" target=\"_blank\">mak@evaxion.ai<\/a><\/p>\n<p align=\"justify\">\n        <b>About Evaxion<\/b><br \/>\n        <br \/>Evaxion is a pioneering TechBio company based upon its AI platform, AI-Immunology\u2122. Evaxion\u2019s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-Immunology\u2122, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients\u2019 lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-Immunology\u2122 platform and vaccine pipeline, please <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bfTUAJAHu4n90YDjlPMMh0JfWhRP7WJj0rJPwCAivFYIz_A6qElqUL_IBf8lqr2kNfDQS2hTLuFeo5fA61x93sS2sRQUMbDtBmvtr1Mb3u4=\" rel=\"nofollow\" target=\"_blank\">visit our website<\/a>.<\/p>\n<p align=\"justify\">\n        <b>Forward-looking statement<\/b>\u00a0<br \/>This\u00a0announcement contains forward-looking statements\u00a0within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.\u00a0The words\u00a0\u201ctarget,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201chope,\u201d \u201caim,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201canticipate,\u201d \u201ccontemplate,\u201d \u201ccontinue,\u201d \u201cestimate,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cwill,\u201d \u201ccan have,\u201d \u201clikely,\u201d \u201cshould,\u201d \u201cwould,\u201d \u201ccould,\u201d and other words and terms of similar meaning\u00a0identify forward-looking statements.\u00a0Actual results may differ materially from those indicated by such forward-looking statements as a result of various factors, including, but not limited to, risks related to: our financial condition and need for additional capital; our development work; cost and success of our product development activities and preclinical and clinical trials; commercializing any approved pharmaceutical product developed using our AI platform technology, including the rate and degree of market acceptance of our product candidates; our dependence on third parties including for conduct of clinical testing and product manufacture; our inability to enter into partnerships; government regulation; protection of our intellectual property rights; employee matters and managing growth; our ADSs and ordinary shares,\u00a0the impact of international economic, political, legal, compliance, social and business factors, including inflation, and the effects on our\u00a0business from other significant geopolitical and macro-economic events;\u00a0and other uncertainties affecting our business operations and financial condition.\u00a0For a further discussion of these risks, please refer to the risk factors included in our most recent Annual Report on Form 20-F\u00a0and other filings\u00a0with the US Securities and Exchange Commission (SEC), which are available at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-fPU4c7QPdZg5Yk5w8ag-LO0CiPIN5jolsSG82Xw0mdE_uQPo-Ojp0U2XaX-2HaS1g881AA37dNsS1d6wl9G4ZgDhWTOliqmM09tfRMon4J98KliYXgrkjtZ6vJEVj9u_dGsZSPMXf-1f4chqnMcHUBopU5re3eUpcgFas8Q4OaCCvqDEW4RM9esv1u-M4jmm8mXqnapoux2x3rgNf1yUFJ-R8_YBrMu3Cy6CiSS-bo=\" rel=\"nofollow\" target=\"_blank\"><b>www.sec.gov<\/b><\/a>.\u00a0We do not assume any obligation to update any forward-looking statements except as required by law.\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTExNzUwMCM0MDIxODIzNTcjMjI1MjA4Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/ZWZlNTk0ZDMtZjFjZi00NDdjLTkyNTgtNWEyMjY1MDE5ZDc4LTEyNjM2NDAtMjAyNS0wNy0xMS1lbg==\/tiny\/Evaxion.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Evaxion and the European Investment Bank (EIB) have finalized a debt settlement agreement of \u20ac3.5 million out of Evaxion\u2019s \u20ac7 million loan with EIB, to be used for EIB to purchase \u20ac3.5 million worth of ordinary Evaxion warrants EIB will purchase the warrants at a price of $4.87 corresponding to a premium of 89% to the share price by market close yesterday The agreement immediately increases Evaxion\u2019s equity by $4.1 million (\u20ac3.5 million) Further, the agreement also substantially reduces Evaxion\u2019s overall liabilities, simplifies its balance sheet and improves its financial flexibility and cash flow COPENHAGEN, Denmark, July 11, 2025 &#8211; Evaxion A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company specializing in developing AI-Immunology\u2122 powered vaccines, has finalized its agreement with &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Evaxion finalizes agreement with EIB to convert debt into equity&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-868798","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Evaxion finalizes agreement with EIB to convert debt into equity - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evaxion finalizes agreement with EIB to convert debt into equity - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Evaxion and the European Investment Bank (EIB) have finalized a debt settlement agreement of \u20ac3.5 million out of Evaxion\u2019s \u20ac7 million loan with EIB, to be used for EIB to purchase \u20ac3.5 million worth of ordinary Evaxion warrants EIB will purchase the warrants at a price of $4.87 corresponding to a premium of 89% to the share price by market close yesterday The agreement immediately increases Evaxion\u2019s equity by $4.1 million (\u20ac3.5 million) Further, the agreement also substantially reduces Evaxion\u2019s overall liabilities, simplifies its balance sheet and improves its financial flexibility and cash flow COPENHAGEN, Denmark, July 11, 2025 &#8211; Evaxion A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company specializing in developing AI-Immunology\u2122 powered vaccines, has finalized its agreement with &hellip; Continue reading &quot;Evaxion finalizes agreement with EIB to convert debt into equity&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-11T12:32:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTExNzUwMCM0MDIxODIzNTcjMjI1MjA4Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Evaxion finalizes agreement with EIB to convert debt into equity\",\"datePublished\":\"2025-07-11T12:32:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\\\/\"},\"wordCount\":664,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTExNzUwMCM0MDIxODIzNTcjMjI1MjA4Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\\\/\",\"name\":\"Evaxion finalizes agreement with EIB to convert debt into equity - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTExNzUwMCM0MDIxODIzNTcjMjI1MjA4Nw==\",\"datePublished\":\"2025-07-11T12:32:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTExNzUwMCM0MDIxODIzNTcjMjI1MjA4Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTExNzUwMCM0MDIxODIzNTcjMjI1MjA4Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evaxion finalizes agreement with EIB to convert debt into equity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evaxion finalizes agreement with EIB to convert debt into equity - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/","og_locale":"en_US","og_type":"article","og_title":"Evaxion finalizes agreement with EIB to convert debt into equity - Market Newsdesk","og_description":"Evaxion and the European Investment Bank (EIB) have finalized a debt settlement agreement of \u20ac3.5 million out of Evaxion\u2019s \u20ac7 million loan with EIB, to be used for EIB to purchase \u20ac3.5 million worth of ordinary Evaxion warrants EIB will purchase the warrants at a price of $4.87 corresponding to a premium of 89% to the share price by market close yesterday The agreement immediately increases Evaxion\u2019s equity by $4.1 million (\u20ac3.5 million) Further, the agreement also substantially reduces Evaxion\u2019s overall liabilities, simplifies its balance sheet and improves its financial flexibility and cash flow COPENHAGEN, Denmark, July 11, 2025 &#8211; Evaxion A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company specializing in developing AI-Immunology\u2122 powered vaccines, has finalized its agreement with &hellip; Continue reading \"Evaxion finalizes agreement with EIB to convert debt into equity\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-11T12:32:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTExNzUwMCM0MDIxODIzNTcjMjI1MjA4Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Evaxion finalizes agreement with EIB to convert debt into equity","datePublished":"2025-07-11T12:32:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/"},"wordCount":664,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTExNzUwMCM0MDIxODIzNTcjMjI1MjA4Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/","name":"Evaxion finalizes agreement with EIB to convert debt into equity - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTExNzUwMCM0MDIxODIzNTcjMjI1MjA4Nw==","datePublished":"2025-07-11T12:32:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTExNzUwMCM0MDIxODIzNTcjMjI1MjA4Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTExNzUwMCM0MDIxODIzNTcjMjI1MjA4Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-finalizes-agreement-with-eib-to-convert-debt-into-equity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Evaxion finalizes agreement with EIB to convert debt into equity"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/868798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=868798"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/868798\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=868798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=868798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=868798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}